The effects of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetine. (Q40799052)
scientific article
Language:
(P31) (Q13442814)
(P304) 261-266
(P407) (Q1860)
(P433) 4
(P478) 8
(P577) Friday, January 1, 1993
(P921) (Q323936)
(P1433) (Q15751307)
(P1476) "The effects of renal and hepatic disease on the pharmacokinetics, renal tolerance, and risk-benefit profile of fluoxetine" (language: en)
(P2093) R F Bergstrom
C M Beasley
N B Levy
M Blumenfield
L Lemberger
(P13046) (Q7318358)
other details
description scientific article

External Links